What is the most common microbial agent transmitted by blood transfusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis C Virus is the Most Common Microbial Agent Transmitted by Blood Transfusion

The most common microbial agent transmitted by blood transfusion is hepatitis C virus (HCV), which historically accounted for the majority of post-transfusion hepatitis cases. 1

Evidence Supporting HCV as the Most Common Transfusion-Transmitted Agent

  • Studies have shown that HCV is the etiologic agent of the majority of parenterally transmitted or bloodborne non-A, non-B hepatitis worldwide 2
  • Historical data demonstrated that 90% of post-transfusion hepatitis in the United States was not due to either hepatitis A or B, but rather to what was later identified as HCV 2, 1
  • Before effective screening was implemented, incidence rates of HCV (then called non-A, non-B hepatitis) were as high as 21% after blood transfusion 2

Comparison with Other Transfusion-Transmitted Agents

Hepatitis B Virus (HBV)

  • By the mid-1970s, improved screening had reduced post-transfusion hepatitis B rates to 0.3%-0.9% per transfusion recipient 2
  • Current incidence of post-transfusion hepatitis B is estimated to be around 0.002% per transfusion recipient 2

Human Immunodeficiency Virus (HIV)

  • HIV transmission through blood transfusion has been dramatically reduced through donor screening 3
  • HIV has never reached the historical prevalence rates of HCV in transfusion recipients

Cytomegalovirus (CMV)

  • While CMV is common in the general population (30-50% of adults show evidence of past infection), it is not the most commonly transmitted agent through blood transfusion 4

Evolution of Blood Safety Measures

  • The shift from paid to volunteer blood donors substantially reduced the incidence of post-transfusion HCV 2
  • Implementation of screening tests has dramatically reduced transmission risks:
    • Anti-HCV antibody screening (initiated in 1990)
    • Nucleic acid testing (NAT) for HCV
    • Surrogate markers like ALT and anti-HBc testing 2, 1

Current Risk Status

  • Modern screening has reduced the risk of HCV transmission to approximately 0.001% per unit transfused 2
  • Despite these improvements, HCV remains historically the most commonly transmitted viral agent through blood transfusion 1

Clinical Implications

  • Patients with abnormal liver function tests after receiving blood products should be tested for HCV and other hepatitis viruses 1
  • The implementation of donor screening has virtually eliminated risks for HCV transmission from transplantation 2

While modern blood screening techniques have dramatically reduced the risk of all transfusion-transmitted infections, the historical data clearly shows that hepatitis C virus has been the most common microbial agent transmitted through blood transfusion.

References

Guideline

Hepatitis C Virus Transmission Through Blood Transfusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Transfusion-transmitted infectious diseases.

Biologicals : journal of the International Association of Biological Standardization, 2009

Research

[Viral risks associated with blood transfusion].

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.